title: Exaggerated blood pressure response to angiotensin II in patients with Cushing's syndrome due to adrenocortical adenoma.
abstract: We studied the roles played by the renin-angiotensin system in inducing hypertension in nine patients with Cushing's syndrome (CS) resulting from adrenocortical adenoma, and compared them with those in patients with primary aldosteronism (PA), renovascular hypertension (RVH) and essential hypertension (EH). In the CS group, each parameter, including serum potassium, plasma renin activity, plasma aldosterone, deoxycorticosterone and corticosterone concentrations, is within the normal range. However, plasma renin activity in the CS group was lower than that in the RVH group but higher than that in the PA group, and plasma aldosterone concentration was lower than that in each RVH or PA group. These findings indicated that the CS group had a different type of hypertension from that in either RVH or PA, in which the renin angiotensin system or mineralocorticoids play an important role in hypertension. Meanwhile, captopril (50 mg) administration either with or without indomethacin pretreatment decreased the mean blood pressure in the CS group, although captopril failed to change it in the PA group or in normal subjects. Furthermore, the pressor response to exogenous angiotensin II in the CS group was higher than that in the RVH or EH group, but was not different from that in the PA group. Thus, the hypertension in patients with CS due to adrenocortical adenoma appears to be mediated through a change in the renin-angiotensin system in the form of exaggerated pressor responses to angiotensin II.
authors: Second Department of Internal Medicine, Yokohama City University School of Medicine, Japan.
authors: G
authors: G
authors: Yasuda
authors: H
authors: H
authors: Shionoiri
authors: S
authors: S
authors: Umemura
authors: I
authors: I
authors: Takasaki
authors: M
authors: M
authors: Ishii
mesh_terms: D000236:Adenoma / Q000150:complications*; D000306:Adrenal Cortex Neoplasms / Q000150:complications*; D000328:Adult; D000450:Aldosterone / Q000097:blood; D000804:Angiotensin II / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D002216:Captopril / Q000494:pharmacology; D003480:Cushing Syndrome / Q000209:etiology* / Q000503:physiopathology*; D003971:Diastole; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006929:Hyperaldosteronism / Q000503:physiopathology; D006973:Hypertension / Q000503:physiopathology; D006978:Hypertension, Renovascular / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D012083:Renin / Q000097:blood
chemical_list: D000804:Angiotensin II; D000450:Aldosterone; D002216:Captopril; D012083:Renin; D006854:Hydrocortisone